Title of article
Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR Original Research Article
Author/Authors
Stephen R. Johnson، نويسنده , , Hongwen Yue، نويسنده , , Mary Lee Conder، نويسنده , , Hong Shi، نويسنده , , Arthur M. Doweyko، نويسنده , , John Lloyd، نويسنده , , Paul Levesque، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
11
From page
6182
To page
6192
Abstract
We describe the development of a computational model for the prediction of the inhibition of K+ flow through the hERG ion channel. Using a collection of 1075 discovery compounds with hERG inhibition measured in our standard patch–clamp electrophysiology assay, molecular features important for drug-induced inhibition were identified using a combination of statistical inference algorithms and manual hypothesis generation and testing. While many of the features used in the model reflect those referenced in the literature, several aspects of the model provide new insight into the role of physicochemical properties, electrostatics, and novel pharmacophores in hERG inhibition. Coefficients for these 10 features were then determined by least median squares regression, resulting in a model with an R2 ∼ 0.66 and RMS error (RMSe) of 0.47 log units for an external test set. Significant additional validation performed using a large collection of subsequent discovery data has been very encouraging with an R2 = 0.54 and an RMSe of 0.63 log units. The performance of the model across several different chemotypes is demonstrated and discussed.
Keywords
HERG , Pharmacophore model , Prolonged QTc , QSAR , Novelty detection , in silico
Journal title
Bioorganic and Medicinal Chemistry
Serial Year
2007
Journal title
Bioorganic and Medicinal Chemistry
Record number
1306003
Link To Document